Raymond James & Associates’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-6,460
Closed -$242K 4221
2021
Q3
$242K Hold
6,460
﹤0.01% 3564
2021
Q2
$294K Sell
6,460
-12
-0.2% -$511 ﹤0.01% 3447
2021
Q1
$252K Buy
6,472
+12
+0.2% +$491 ﹤0.01% 3477
2020
Q4
$252K Buy
+6,460
New +$228K ﹤0.01% 3239

Other funds holding KURE

Raymond James & Associates's KURE Position: Q4 2021 in Review

Raymond James & Associates sold out of KraneShares MSCI All China Health Care Index ETF (KURE) in Q4 2021, closing a stake of 6,460 shares — an estimated $242K sold.

Raymond James & Associates first reported a position in KURE in Q4 2020 and held it in 4 quarters. The position peaked at $294K in Q2 2021. 27 funds tracked by Wall St. Rank hold KURE as of Q4 2021.

  • Raymond James & Associates reported no remaining KraneShares MSCI All China Health Care Index ETF position as of Q4 2021 after selling out during the quarter.
  • Raymond James & Associates sold 6,460 KraneShares MSCI All China Health Care Index ETF shares in Q4 2021, an estimated $242K.
  • Raymond James & Associates first reported a position in KraneShares MSCI All China Health Care Index ETF in Q4 2020 and held it in 4 quarters.
  • Raymond James & Associates's KraneShares MSCI All China Health Care Index ETF position peaked at $294K in Q2 2021.
  • 27 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q4 2021.

Based on Raymond James & Associates's 13F filing for Q4 2021, filed 8 Feb 2022.